Publicaciones en las que colabora con FLOR ANGEL ORDOÑEZ ALVAREZ (12)

2017

  1. Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine

    Pediatric Research, Vol. 82, Núm. 1, pp. 148-154

  2. Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome

    PLoS ONE, Vol. 12, Núm. 3

2015

  1. Chronic kidney disease induced by adenine: A suitable model of growth retardation in uremia

    American Journal of Physiology - Renal Physiology, Vol. 309, Núm. 1, pp. F57-F62

  2. Clinical and laboratory approaches in the diagnosis of renal tubular acidosis

    Pediatric Nephrology, Vol. 30, Núm. 12, pp. 2099-2107

2013

  1. Dent’s disease: Identification of seven new pathogenic mutations in the CLCN5 gene

    Journal of Pediatric Genetics, Vol. 2, Núm. 3, pp. 133-140

  2. Genetics of Type III Bartter Syndrome in Spain, Proposed Diagnostic Algorithm

    PLoS ONE, Vol. 8, Núm. 9

  3. Hypophosphatemia and growth

    Pediatric Nephrology, Vol. 28, Núm. 4, pp. 595-603

2012

  1. Growth hormone improves growth retardation induced by rapamycin without blocking its antiproliferative and antiangiogenic effects on rat growth plate

    PLoS ONE, Vol. 7, Núm. 4

2009

  1. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: Effect of growth hormone treatment

    American Journal of Physiology - Renal Physiology, Vol. 297, Núm. 3

2007

  1. Distal RTA with nerve deafness: Clinical spectrum and mutational analysis in five children

    Pediatric Nephrology, Vol. 22, Núm. 6, pp. 825-828

  2. Rapamycin retards growth and causes marked alterations in the growth plate of young rats

    Pediatric Nephrology, Vol. 22, Núm. 7, pp. 954-961

2006

  1. Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it

    Kidney International, Vol. 70, Núm. 11, pp. 1955-1961